ATE358490T1 - Verwendung einer kombination aus einem purin und einem no-donor zur behandlung und prophylaxe sexueller funktionsstörungen - Google Patents
Verwendung einer kombination aus einem purin und einem no-donor zur behandlung und prophylaxe sexueller funktionsstörungenInfo
- Publication number
- ATE358490T1 ATE358490T1 AT99958233T AT99958233T ATE358490T1 AT E358490 T1 ATE358490 T1 AT E358490T1 AT 99958233 T AT99958233 T AT 99958233T AT 99958233 T AT99958233 T AT 99958233T AT E358490 T1 ATE358490 T1 AT E358490T1
- Authority
- AT
- Austria
- Prior art keywords
- purine
- combination
- donor
- prophylaxis
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9815237A FR2786699B1 (fr) | 1998-12-02 | 1998-12-02 | Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE358490T1 true ATE358490T1 (de) | 2007-04-15 |
Family
ID=9533506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99958233T ATE358490T1 (de) | 1998-12-02 | 1999-12-02 | Verwendung einer kombination aus einem purin und einem no-donor zur behandlung und prophylaxe sexueller funktionsstörungen |
Country Status (12)
Country | Link |
---|---|
US (2) | US6506736B1 (de) |
EP (1) | EP1137420B1 (de) |
JP (1) | JP2002531408A (de) |
AT (1) | ATE358490T1 (de) |
AU (1) | AU1564500A (de) |
CY (1) | CY1106702T1 (de) |
DE (1) | DE69935733T2 (de) |
DK (1) | DK1137420T3 (de) |
ES (1) | ES2285865T3 (de) |
FR (1) | FR2786699B1 (de) |
PT (1) | PT1137420E (de) |
WO (1) | WO2000032202A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2786699B1 (fr) * | 1998-12-02 | 2002-10-04 | Philippe Gorny | Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles |
WO2007075151A1 (en) * | 2005-12-29 | 2007-07-05 | Victor Pavlovich Kutnyak | Composite vasodilator based on a no-group donator and a promoter |
FR3005262A1 (fr) | 2013-05-02 | 2014-11-07 | Philippe Gorny | Nouvelles compositions pharmaceutiques ou dietetiques permettant de masquer totalement l'amertume des sels d'arginine donnes a haute dose, sous forme liquide ou semi-liquide. |
FR3012039A1 (fr) * | 2013-10-22 | 2015-04-24 | Philippe Olivier Gorny | Medicament ou produit dietetique et son utilisation pour prevenir ou traiter les dysfonctionnements sexuels de l'homme et de la femme |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63179827A (ja) * | 1987-01-20 | 1988-07-23 | Fuso Yakuhin Kogyo Kk | アデノシン三リン酸とマグネシウムイオンを含む安定な製剤 |
DE4117249C2 (de) * | 1991-05-27 | 1998-05-14 | Christian Dr Stief | Linsidomin zur Behandlung erektiler Dysfunktionen |
RU2064792C1 (ru) * | 1992-03-02 | 1996-08-10 | Свистов Александр Сергеевич | Антиангинальное жидкое средство для трансдермального применения |
GB2268871A (en) * | 1992-07-04 | 1994-01-26 | Bio Nutritional Health Service | Composition for use as a food or food supplement |
DK100392D0 (da) * | 1992-08-10 | 1992-08-10 | Gea Farmaceutisk Fabrik As | 3- og 5-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende disse forbindelser samt forbindelsernes anvendelse til fremstilling af laegemidler |
BR9203277A (pt) * | 1992-08-21 | 1994-03-01 | Cesar Roberto Dias Nahoum | Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao |
US5910316A (en) * | 1992-08-24 | 1999-06-08 | The United States Of America, As Represented By The Department Of Health And Human Services | Use of nitric oxide-releasing agents to treat impotency |
US5422343A (en) * | 1992-12-21 | 1995-06-06 | Otsuka Pharmaceutical Factory, Inc. | Prophylactic and therapeutic composition for MRSA infection |
US5594032A (en) * | 1994-11-10 | 1997-01-14 | Gonzalez-Cadavid; Nestor F. | Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA |
US5612060A (en) * | 1995-05-25 | 1997-03-18 | Alexander; J. Wesley | Enhancement of transplant graft survival through nutritional immunomodulation and immunosuppressive therapy |
JP4526047B2 (ja) * | 1995-11-08 | 2010-08-18 | 雪印乳業株式会社 | 体力増強剤 |
US5824669A (en) * | 1996-03-22 | 1998-10-20 | Nitromed, Inc. | Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
GB9608408D0 (en) * | 1996-04-23 | 1996-06-26 | Adams Michael A | Treatment of erectile dysfunction |
US5877216A (en) * | 1997-10-28 | 1999-03-02 | Vivus, Incorporated | Treatment of female sexual dysfunction |
US6127363A (en) * | 1997-10-28 | 2000-10-03 | Vivus, Inc. | Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction |
US6124461A (en) * | 1998-05-26 | 2000-09-26 | Saint Louis University, Health Services Center, Research Administration | Compounds, compositions, and methods for treating erectile dysfunction |
WO2000000212A1 (en) * | 1998-06-26 | 2000-01-06 | Nutracorp Scientific, Inc. | Promoting nitric oxide and cyclic gmp activity |
US6007824A (en) * | 1998-07-09 | 1999-12-28 | Duckett; Melvin J. | Natural composition and method for the treatment of sexual dysfunction |
FR2786699B1 (fr) * | 1998-12-02 | 2002-10-04 | Philippe Gorny | Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles |
-
1998
- 1998-12-02 FR FR9815237A patent/FR2786699B1/fr not_active Expired - Fee Related
-
1999
- 1999-12-02 WO PCT/FR1999/002993 patent/WO2000032202A1/fr active IP Right Grant
- 1999-12-02 EP EP99958233A patent/EP1137420B1/de not_active Expired - Lifetime
- 1999-12-02 AU AU15645/00A patent/AU1564500A/en not_active Abandoned
- 1999-12-02 AT AT99958233T patent/ATE358490T1/de active
- 1999-12-02 JP JP2000584897A patent/JP2002531408A/ja active Pending
- 1999-12-02 ES ES99958233T patent/ES2285865T3/es not_active Expired - Lifetime
- 1999-12-02 DE DE69935733T patent/DE69935733T2/de not_active Expired - Lifetime
- 1999-12-02 DK DK99958233T patent/DK1137420T3/da active
- 1999-12-02 PT PT99958233T patent/PT1137420E/pt unknown
-
2000
- 2000-07-12 US US09/614,694 patent/US6506736B1/en not_active Expired - Lifetime
-
2002
- 2002-12-13 US US10/248,060 patent/US20030195165A1/en not_active Abandoned
-
2007
- 2007-07-04 CY CY20071100889T patent/CY1106702T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK1137420T3 (da) | 2007-08-06 |
WO2000032202A1 (fr) | 2000-06-08 |
FR2786699B1 (fr) | 2002-10-04 |
EP1137420A1 (de) | 2001-10-04 |
JP2002531408A (ja) | 2002-09-24 |
DE69935733T2 (de) | 2007-12-27 |
ES2285865T3 (es) | 2007-11-16 |
PT1137420E (pt) | 2007-07-04 |
DE69935733D1 (de) | 2007-05-16 |
US6506736B1 (en) | 2003-01-14 |
US20030195165A1 (en) | 2003-10-16 |
FR2786699A1 (fr) | 2000-06-09 |
AU1564500A (en) | 2000-06-19 |
CY1106702T1 (el) | 2012-05-23 |
EP1137420B1 (de) | 2007-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1021179A4 (de) | Verfahren zur förderung des haarwuchses und entwicklung des haarsystems | |
ATE301459T1 (de) | Norbornen- und norbornandiolen zur behandlung von pigmentierungsstörungen, neurodegenerativen erkrankungen oder proliferativen hauterkrankungen | |
WO1998010767A3 (en) | Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders | |
CY1107323T1 (el) | Αναστολεις πρωτεασωμικης δρασης για διεγepση τριχοφυϊας | |
EP1041880A4 (de) | Verabreichung von arginin zur erzielung eines wohltuenden effektes | |
ATE119386T1 (de) | Äusserlich anzuwendende analgetische lotion und verfahren zur herstellung. | |
ATE186834T1 (de) | Verwendung von wirksamen mengen von aktiven stoffen zur behandlung von mischhaut | |
NO994640D0 (no) | Hostestillende midler | |
WO2002064088A3 (en) | Pharmaceutical composition for the treatment of alopecia | |
DE69902520D1 (de) | Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden | |
JPH08107936A (ja) | 毛髪発毛育毛方法及び装置 | |
DE60119976D1 (en) | Thixotropes nasenspray | |
ATE358490T1 (de) | Verwendung einer kombination aus einem purin und einem no-donor zur behandlung und prophylaxe sexueller funktionsstörungen | |
ATE122873T1 (de) | Kombination aus minoxidil und einer antiinflammatorischen substanz zur behandlung der alopezie. | |
DE69932922D1 (de) | Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen | |
DE69822276D1 (de) | Kräuter formulierung mit therapeutischer und kosmetischer verwendung zur behandlung von allgemeinen hauterkrankungen | |
ATE204476T1 (de) | Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem | |
DE69900774D1 (de) | Verwendung von topische präparationen mit glyceryl trinitrat und lanolin zur behandlung von erektilen funktionsstörungen | |
ATE30114T1 (de) | Mittel zur pflege oder behandlung der menschlichen haut. | |
SE9904863D0 (sv) | New use | |
Wantke et al. | Topical podophyllotoxin in psoriasis vulgaris | |
DE3775278D1 (de) | Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen. | |
HUP0101602A2 (hu) | Termékenységet javító készítmény, és annak alkalmazása | |
UA29192A (uk) | Концентратор енергії | |
ATE164766T1 (de) | Zusammensetzung aus asphodelus zur erhöhung der anzahl weisser blutzellen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1137420 Country of ref document: EP |